Atara Biotherapeutics
ATRA
#9219
Rank
NZ$0.12 B
Marketcap
$21.57
Share price
-6.39%
Change (1 day)
-2.20%
Change (1 year)

Revenue for Atara Biotherapeutics (ATRA)

Revenue in 2024 (TTM): NZ$0.16 Billion

According to Atara Biotherapeutics's latest financial reports the company's current revenue (TTM ) is NZ$0.17 Billion. In 2023 the company made a revenue of NZ$13.55 Million a decrease over the revenue in the year 2022 that were of NZ$0.10 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Atara Biotherapeutics from 2013 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) NZ$0.16 B1101.51%
2023 NZ$13.55 M-86.46%
2022 NZ$0.10 B236.25%
2021 NZ$29.77 M
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NZ$0.28 B 59.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.7 M-99.04%๐Ÿ‡ฉ๐Ÿ‡ช Germany
NZ$0.51 B 186.36%๐Ÿ‡บ๐Ÿ‡ธ USA